Doctors at the Urology Group are pioneering the use of artificial intelligence to enhance prostate cancer treatment, offering ...

A 68-year-old man presented to the emergency department with haematuria and penile pain. His medical history included benign prostatic hyperplasia, but no follow-up examinations had been performed.

Nonlinear improvement seen in relative benefit of distant metastasis, OS, with reduced benefits beyond nine to 12 months of ADT.

As the prostate cancer treatment landscape continues to evolve, understanding the risks and benefits of each approach is critical for patients. Prostate cancer treatment continues to evolve, and ...

In this meta-analysis, researchers evaluated the use and/or prolongation of ADT in men with non-metastatic prostate cancer undergoing definitive radiotherapy. For men with prostate cancer treated with ...

FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Syncromune®, Inc., a clinical-stage biopharmaceutical ...

An error has occurred. Please try again. With a Lewiston Sun Journal subscription, you can gift 5 articles each month. It looks like you do not have any active ...

A groundbreaking trial for a prostate cancer treatment with fewer side effects has launched in the UK. Backed by the ...

John Tesh was diagnosed with prostate cancer despite having a low PSA and given 18 months to live back in 2015. Now, 10 years ...

Telix Pharmaceuticals has dosed its first patient for the second part of a global study to evaluate the lead prostate cancer ...

Archeus Technologies, a company developing multiple differentiated radiopharmaceutical therapies for the treatment of patients with cancer, today announced that it has dosed the first patient in its ...

MRI system significantly improves prostate cancer detection and efficiency. Find out how ProAI boosts accuracy and reduces ...